Episode # 70 • 25 Feb 2025
Frontiers in Musculoskeletal Embolization
Musculoskeletal embolization is generating significant excitement in the field of chronic pain management. In this episode, Dr. Jacob Fleming hosts a discussion with Dr. Yuji Okuno from Japan, a pioneer in both basic science and clinical practice within the field of musculoskeletal embolization.
This podcast is supported by
Timestamps
00:00 - Introduction
01:54 - Origins of Embolization for Pain
04:15 - Basic Science Research Discoveries and Clinical Trials
09:02 - Temporary Embolic Materials
15:28 - Techniques for Embolization
17:33 - Plantar Fasciitis Treatment
24:04 - Future of Embolization in Sports Injuries
28:11 - Diagnostic Imaging in Embolization
36:10 - Global Expansion and Collaborations
You may also like
More about this episode
The conversation delves into Dr. Okuno's groundbreaking work using embolization to treat chronic pain from conditions such as frozen shoulder, knee osteoarthritis, plantar fasciitis, and various sports injuries. Dr. Okuno discusses the development of new temporary embolic agents and compares different approaches to embolization treatments, including the innovative use of antibiotics as embolic material. The doctors also cover the intriguing concept of differential recanalization, where abnormal inflammatory vessels are less likely to recanalize than normal vessels after embolic treatment. Identifying hypervascularity through MRI, ultrasound, or angiogram is a crucial step before attempting embolization.
Overall, Dr. Okuno offers valuable insights into his clinical practice and the potential for groundbreaking advancements in musculoskeletal care worldwide.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.